Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Taysha Gene Therapies, Inc. (TSHA) had Free Cash Flow per Share of $-0.11 for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-42.41M |
|
-- |
|
-- |
|
$43.49M |
|
$-43.49M |
|
$1.08M |
|
$-42.41M |
|
$-42.41M |
|
$-42.41M |
|
$-42.41M |
|
$-42.41M |
|
$-42.41M |
|
$-43.49M |
|
$-43.19M |
|
366.63M |
|
366.63M |
|
$-0.12 |
|
$-0.12 |
|
| Balance Sheet Financials | |
$282.25M |
|
$6.45M |
|
$18.10M |
|
$300.35M |
|
$20.10M |
|
$48.96M |
|
$68.31M |
|
$88.41M |
|
$211.94M |
|
$211.94M |
|
$211.94M |
|
287.28M |
|
| Cash Flow Statement Financials | |
$-40.88M |
|
$-3.02M |
|
$0.71M |
|
$322.53M |
|
$279.34M |
|
$-43.19M |
|
$5.55M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
14.04 |
|
-- |
|
-- |
|
0.19 |
|
0.23 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-40.90M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-20.01% |
|
-20.01% |
|
-14.12% |
|
-16.25% |
|
$0.74 |
|
|
Free Cash Flow per Share |
$-0.11 |
$-0.11 |
|